Cargando…
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
AIMS: To describe the total cardiovascular burden (cardiovascular morbidity or mortality, revascularization or non-traumatic amputation) in individuals with screen-detected diabetes in the ADDITION-Europe trial and to quantify the impact of the intervention on multiple cardiovascular events over 5 y...
Autores principales: | Simmons, R K, Sharp, S J, Sandbæk, A, Borch-Johnsen, K, Davies, M J, Khunti, K, Lauritzen, T, Rutten, G E H M, van den Donk, M, Wareham, N J, Griffin, S J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698698/ https://www.ncbi.nlm.nih.gov/pubmed/22823477 http://dx.doi.org/10.1111/j.1464-5491.2012.03759.x |
Ejemplares similares
-
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
por: Griffin, Simon J, et al.
Publicado: (2011) -
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial
por: Black, J A, et al.
Publicado: (2014) -
Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial
por: Van den Donk, Maureen, et al.
Publicado: (2013) -
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
por: Tao, L, et al.
Publicado: (2015) -
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
por: Sandbaek, A., et al.
Publicado: (2008)